Alycia Rafter, MS

Senior Sales Support/Data Governance Specialist II at Boston Heart Diagnostics

Alycia Rafter, MS has extensive work experience in various positions. Alycia began their career as a Customer Service Coordinator at TJ Maxx in 2004 and worked there until 2009. From 2007 to 2009, they also served as a Relief Clinical Counselor at YOU, Inc. In 2009, Alycia joined AdCare Hospital as a Secretary/Receptionist, a position they held until 2010. Following this, they worked at Integrated Genetics from 2010 to 2014, first as a Client Services Support and then as a Client Services Team Lead. Most recently, Alycia worked at Boston Heart Diagnostics from 2014 to the present. During their tenure, they held various roles including Sales Support Representative, Sales Support Representative II, Regional Sales Support Representative-Southeast, and Senior Sales Support/Data Governance Specialist II.

Alycia Rafter, MS pursued their higher education at Worcester State University. From 2005 to 2009, they completed their Bachelor's degree in Business Administration. Afterward, from 2010 to 2012, they continued their education at the same university, obtaining a Master's degree in Leadership and Management.

Location

Boston, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Boston Heart Diagnostics

Boston Heart Lab is a healthcare company that provides cardiovascular disease (CVD) management. Through there combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management.Unlike other lipid testing companies that are focused on the primary screening market for CVD, their proprietary testing technology allows for the ongoing monitoring of a patient's disease and precise determination of the most appropriate pharmaceutical alternatives. They can provide unique, personalized treatment options to patients with dyslipidemia to determine the efficacy of lipid adjusting drugs in most cases within the first 6 weeks of treatment. Competing methods usually need 6 months.